The law firm of Lieff
Cabraser Heimann & Bernstein, LLP reminds investors of the
upcoming deadline to move for appointment as lead plaintiff in
securities class litigation brought on behalf of investors who purchased
or otherwise acquired the securities of Nobilis Health Corporation
(“Nobilis” or the “Company”) (NYSE: HLTH) between April 2, 2015 and
January 6, 2016, inclusive (the “Class Period”).
If you purchased or acquired Nobilis securities during the Class Period,
you may move the Court for appointment as lead plaintiff by no later
than March 21, 2016. A lead plaintiff is a representative party who acts
on behalf of other class members in directing the litigation. Your share
of any recovery in the action will not be affected by your decision of
whether to seek appointment as lead plaintiff. You may retain Lieff
Cabraser, or other attorneys, as your counsel in the action.
Nobilis investors who wish to learn more about the action and how to
seek appointment as lead plaintiff should click
here or contact
Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358.
The action alleges that defendants made false and/or misleading
statements and/or failed to disclose that: (i) Nobilis’s financial
statements contained numerous errors concerning the Company’s
classification of warrants and options, business combination accounting,
share-based compensation, and other financial and operating results;
(ii) Nobilis had overstated its net income for the year ended December
31, 2014 by more than $4 million; and (iii) Nobilis had overstated its
net income for the quarter ended March 31, 2015 by more than $3.27
million.
On January 5, 2016, after the market closed, Nobilis disclosed that its
financial statements for the fiscal year ended December 31, 2014, the
quarters ended March 31, 2015 and June 30, 2015, and the financial
statements in its updated S-1 registration statement filed on October
23, 2015 can no longer be relied upon.
On January 7, 2016, before the market opened, Nobilis announced that its
Chief Executive Officer had resigned. On this news, Nobilis stock fell
$0.63 per share, or 20.32%, to close at $2.47 per share on January 7,
2016.
About Lieff Cabraser
Lieff Cabraser Heimann & Bernstein, LLP is a nationally recognized law
firm committed to advancing investor rights and promoting corporate
responsibility.
For thirteen years, the National Law Journal has selected Lieff
Cabraser as one of the top plaintiffs’ law firms in the nation. Best
Lawyers and U.S. News have also named Lieff Cabraser as a
“Law Firm of the Year” each year the publications have given this award
to law firms.
For more information about Lieff Cabraser and the firm’s representation
of investors, please visit http://www.lieffcabraser.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160210005435/en/
Copyright Business Wire 2016